RVNC
Marshall Wace’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-252,468
| Closed | -$768K | – | 3014 |
|
|
2024
Q4 | $768K | Sell |
252,468
-314,832
| -55% | -$957K | ﹤0.01% | 1730 |
|
|
2024
Q3 | $2.94M | Buy |
+567,300
| New | +$2.94M | ﹤0.01% | 1129 |
|
|
2024
Q2 | – | Sell |
-781,223
| Closed | -$3.84M | – | 2808 |
|
|
2024
Q1 | $3.84M | Buy |
+781,223
| New | +$3.84M | 0.01% | 970 |
|
|
2023
Q4 | – | Sell |
-713,638
| Closed | -$8.19M | – | 2387 |
|
|
2023
Q3 | $8.19M | Buy |
713,638
+623,110
| +688% | +$7.15M | 0.02% | 648 |
|
|
2023
Q2 | $2.29M | Buy |
+90,528
| New | +$2.29M | ﹤0.01% | 1100 |
|
|
2022
Q4 | – | Sell |
-41,253
| Closed | -$1.12M | – | 2960 |
|
|
2022
Q3 | $1.12M | Buy |
41,253
+24,395
| +145% | +$659K | ﹤0.01% | 1765 |
|
|
2022
Q2 | $233K | Sell |
16,858
-105,740
| -86% | -$1.46M | ﹤0.01% | 2415 |
|
|
2022
Q1 | $2.39M | Buy |
+122,598
| New | +$2.39M | ﹤0.01% | 1562 |
|
|
2019
Q2 | – | Sell |
-30,675
| Closed | -$483K | – | 1894 |
|
|
2019
Q1 | $483K | Buy |
+30,675
| New | +$483K | ﹤0.01% | 1138 |
|